A tocotrienol-enriched formulation protects against radiation-induced changes in cardiac mitochondria without...

Area of Science:

• Cardiology
• Radiation Oncology
• Mitochondrial Biology

Background:

• Radiation-induced heart disease (RIHD) is a serious complication of chest radiation therapy.
• Mitochondrial dysfunction and permeability transition pore (mPTP) opening are key factors in RIHD.
• Tocotrienols are known antioxidants with potential to mitigate oxidative stress-induced mitochondrial damage.

Purpose of the Study:

• To investigate the protective effects of tocotrienols against radiation-induced mitochondrial alterations.
• To evaluate the impact of tocotrienols on the structural and functional consequences of RIHD.
• To determine if tocotrienol intervention can prevent long-term cardiac dysfunction post-irradiation.

Main Methods:

• Male Sprague-Dawley rats underwent localized heart irradiation (21 Gy).
• Rats received a tocotrienol-enriched formulation or vehicle orally 24 hours before irradiation.
• Mitochondrial function, membrane parameters, cardiac function, and histology were assessed at 2 and 28 weeks post-irradiation.

Main Results:

• Tocotrienols preserved the Bax/Bcl2 ratio, indicating reduced apoptosis.
• Tocotrienol treatment prevented mPTP opening and normalized radiation-induced changes in mitochondrial respiration.
• Despite mitochondrial protection, tocotrienols did not significantly alter long-term cardiac function or myocardial remodeling.

Conclusions:

• A single dose of tocotrienols effectively protects against acute radiation-induced mitochondrial damage.
• Tocotrienol's protective effects on mitochondria are insufficient to prevent late-stage structural and functional cardiac damage from radiation.
• Further research is needed to explore therapeutic strategies for mitigating long-term RIHD.